
Ann Hynes
Stock Analyst at Mizuho Securities
(4.85)
# 401
Out of 5,133 analysts
1161
Total ratings
63.6%
Success rate
11.5%
Average return
Main Sectors:
Stocks Rated by Ann Hynes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARDT Ardent Health | Reiterated: Buy | $13 → $21 | $17.80 | +17.98% | 9 | Nov 11, 2026 | |
| FTRE Fortrea Holdings | Downgraded: Sell | $19 | $20.20 | -5.94% | 17 | Nov 11, 2026 | |
| HCA HCA Healthcare | Reiterated: Buy | $495 → $570 | $499.05 | +14.22% | 66 | Nov 11, 2026 | |
| HUM Humana | Reiterated: Buy | $495 → $530 | $450.00 | +17.78% | 49 | Nov 11, 2026 | |
| MD Pediatrix Medical Group | Downgraded: Sell | $28 | $31.30 | -10.54% | 47 | Nov 11, 2026 | |
| SGRY Surgery Partners | Downgraded: Hold | $19 → $25 | $26.95 | -7.24% | 18 | Nov 11, 2026 | |
| THC Tenet Healthcare | Reiterated: Buy | $305 → $330 | $286.03 | +15.37% | 56 | Nov 11, 2026 | |
| UHS Universal Health Services | Reiterated: Buy | $200 → $225 | $194.07 | +15.94% | 63 | Nov 11, 2026 | |
| CON Concentra Group Holdings Parent | Reiterated: Buy | $40 → $47 | $42.55 | +10.46% | 12 | Nov 9, 2026 | |
| ACHC Acadia Healthcare Company | Reiterated: Hold | $31 → $36 | $37.78 | -4.71% | 47 | Nov 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $295 → $315 | $337.97 | -6.80% | 17 | Nov 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $355 → $400 | $370.48 | +7.97% | 63 | Nov 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $140 → $155 | $140.99 | +9.94% | 43 | Nov 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $190 → $228 | $194.65 | +17.13% | 54 | Nov 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $69 → $72 | $71.27 | +1.02% | 39 | Oct 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $470 → $490 | $429.69 | +14.04% | 47 | Oct 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $700 → $730 | $653.94 | +11.63% | 16 | Oct 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $493 → $500 | $407.46 | +22.71% | 58 | Oct 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $275 → $300 | $265.12 | +13.16% | 54 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $86 | $71.21 | +20.77% | 21 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $260 | $259.60 | +0.15% | 65 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 → $120 | $89.35 | +34.30% | 74 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $215 → $255 | $209.49 | +21.72% | 36 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $330 → $340 | $297.00 | +14.48% | 38 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $359.03 | n/a | 38 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1,102.81 | n/a | 52 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $110 | $281.10 | n/a | 43 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $220 | $155.10 | n/a | 1 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $661.19 | n/a | 1 | Sep 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $70.38 | n/a | 1 | Apr 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4.5 → $3.6 | $2.24 | n/a | 16 | Jul 27, 2018 |
Ardent Health
Nov 11, 2026
Reiterated: Buy
Price Target: $13 → $21
Current: $17.80
Upside: +17.98%
Fortrea Holdings
Nov 11, 2026
Downgraded: Sell
Price Target: $19
Current: $20.20
Upside: -5.94%
HCA Healthcare
Nov 11, 2026
Reiterated: Buy
Price Target: $495 → $570
Current: $499.05
Upside: +14.22%
Humana
Nov 11, 2026
Reiterated: Buy
Price Target: $495 → $530
Current: $450.00
Upside: +17.78%
Pediatrix Medical Group
Nov 11, 2026
Downgraded: Sell
Price Target: $28
Current: $31.30
Upside: -10.54%
Surgery Partners
Nov 11, 2026
Downgraded: Hold
Price Target: $19 → $25
Current: $26.95
Upside: -7.24%
Tenet Healthcare
Nov 11, 2026
Reiterated: Buy
Price Target: $305 → $330
Current: $286.03
Upside: +15.37%
Universal Health Services
Nov 11, 2026
Reiterated: Buy
Price Target: $200 → $225
Current: $194.07
Upside: +15.94%
Concentra Group Holdings Parent
Nov 9, 2026
Reiterated: Buy
Price Target: $40 → $47
Current: $42.55
Upside: +10.46%
Acadia Healthcare Company
Nov 6, 2026
Reiterated: Hold
Price Target: $31 → $36
Current: $37.78
Upside: -4.71%
Nov 6, 2026
Reiterated: Hold
Price Target: $295 → $315
Current: $337.97
Upside: -6.80%
Nov 4, 2026
Reiterated: Buy
Price Target: $355 → $400
Current: $370.48
Upside: +7.97%
Nov 2, 2026
Reiterated: Buy
Price Target: $140 → $155
Current: $140.99
Upside: +9.94%
Nov 2, 2026
Reiterated: Buy
Price Target: $190 → $228
Current: $194.65
Upside: +17.13%
Oct 28, 2026
Reiterated: Hold
Price Target: $69 → $72
Current: $71.27
Upside: +1.02%
Oct 23, 2026
Reiterated: Buy
Price Target: $470 → $490
Current: $429.69
Upside: +14.04%
Oct 23, 2026
Reiterated: Buy
Price Target: $700 → $730
Current: $653.94
Upside: +11.63%
Oct 22, 2026
Reiterated: Buy
Price Target: $493 → $500
Current: $407.46
Upside: +22.71%
Oct 7, 2026
Reiterated: Buy
Price Target: $275 → $300
Current: $265.12
Upside: +13.16%
Jul 31, 2026
Reiterated: Buy
Price Target: $86
Current: $71.21
Upside: +20.77%
Jul 28, 2026
Reiterated: Buy
Price Target: $260
Current: $259.60
Upside: +0.15%
Jul 13, 2026
Reiterated: Buy
Price Target: $115 → $120
Current: $89.35
Upside: +34.30%
Jul 13, 2026
Reiterated: Buy
Price Target: $215 → $255
Current: $209.49
Upside: +21.72%
Jun 8, 2026
Reiterated: Buy
Price Target: $330 → $340
Current: $297.00
Upside: +14.48%
Mar 7, 2025
Reiterated: Buy
Price Target: n/a
Current: $359.03
Upside: n/a
Nov 6, 2024
Reiterated: Hold
Price Target: n/a
Current: $1,102.81
Upside: n/a
Nov 4, 2024
Rated: Hold
Price Target: $110
Current: $281.10
Upside: n/a
Nov 8, 2022
Reiterated: Hold
Price Target: $220
Current: $155.10
Upside: n/a
Sep 12, 2022
Reiterated: Buy
Price Target: n/a
Current: $661.19
Upside: n/a
Apr 11, 2022
Reiterated: Buy
Price Target: n/a
Current: $70.38
Upside: n/a
Jul 27, 2018
Reiterated: Hold
Price Target: $4.5 → $3.6
Current: $2.24
Upside: n/a